Quickly Find Models to Fit Your Research NeedsUnderstanding the genetic drivers behind tumorigenesis is critical for the development of cancer therapeutics. Scientists at CrownBio have deployed the latest genomic characterization technologies to understand the genetic background of a wide range of our models, covering:Cell lines and their associated ValidatedXeno™ xenograftsHuPrime® Patient-Derived Xenograft (PDX) modelsOur standard and novel immunotherapy platformsincluding syngeneic tumor models, MuPrime™, and HuGEMM™ modelsCollating all of these data in our easy to use online databases and model search engine provides a fast and uncomplicated method for our clients to understand the comprehensive genetic context behind the response to their compounds, and to find models to fit their further research needs.